NOT KNOWN DETAILS ABOUT KEYTRUDA COST

Critique Pembrolizumab (Keytruda): CADTH Reimbursement Advice: Indication: In combination with chemotherapy, with the treatment method of adult people with regionally recurrent unresectable or metastatic triple-destructive breast most cancers who may have not acquired prior chemotherapy for metastatic disease and whose tumours express programmed mo